ZBH NYSE Week ended 31 Jul 2026

Weekly Investor Report

Zimmer Biomet Holdings Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 93.93 USD
2.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 4.7% above the Trend Line and sits at 53.1% of its 52-week range. The latest completed week returned 2.8%, after a 7.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 55/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 3d.

Setup score 50 out of 100
Latest Close 93.93 USD 31 Jul 2026
1W Return 2.8% latest completed week
4W Return 7.4% short-term follow-through
12W Return 14.4% quarterly tape
Trend Breadth 5.8% 3 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.8% Latest completed week; four-week move 7.4%. Indicator stack 3/93 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 55/100 conviction; expected move 9.1%. News sentiment 56/100 56 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 4.7% above the Trend Line and sits at 53.1% of its 52-week range. The latest completed week returned 2.8%, after a 7.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1812-week average 0.12

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.4% over four weeks, 14.4% over 12 weeks, and 4.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.8%
4W7.4%
12W14.4%
26W8.5%
52W4.7%
Active trend streak0 weeks
Active weeks in one year3
Trend breadth5.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.65Latest activity-pressure read.
Pressure change390.8%Four-week change in activity pressure.
Leadership-7.23Latest relative-leadership reading.
RS change50.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value68/100Relative valuation strength. Underlying universe rank 33; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum24/100Medium-term price momentum. Underlying universe rank 77; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework42/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
23.2x
Price divided by trailing earnings.
Price / sales
2.1x
Market value relative to trailing revenue.
EV / EBITDA
11.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
70.0%
Gross profit retained from each unit of revenue.
Operating margin
14.3%
Operating profit retained from revenue.
Free-cash-flow margin
24.6%
Free cash flow generated from revenue.
Return on invested capital
5.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
9.2%
Latest one-year revenue growth.
EPS growth
-16.7%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
5.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.1%
Cash dividends relative to market value.
Buyback yield
2.7%
Net share repurchases relative to market value.
Shareholder yield
3.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

ZBH shows bearish options pressure with a 55/100 conviction score, put-call volume ratio of 2.44, expected move of 9.1%, and Sharemaestro trend signal inactive.

Conviction55/100
Expected move9.1%
Put/call volume2.44
Pressure-39
Speculation40
Volatility70
Trend agreement87
Open options detail
Insider activity18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 56 relevant articles.

20 positive · 30 neutral · 6 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move9.1%Nearest-chain priced movement where available.
52-week drawdown-12.4%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+7.3%Week of 13 Feb.
Worst week-9.2%Week of 1 May.
Latest week+2.8%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains11
Flat weeks0
Modest losses7
Sharp losses4
Recent vol3.4%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape43/100

Trend, activity pressure, participation, and risk combine to a 43/100 tape read.

 Indicator analysis20/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.18; No reversal markers Factors59/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 19; Small Cap Core rank 33 SVQF42/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 593.0 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options48/100

ZBH shows bearish options pressure with a 55/100 conviction score, put-call volume ratio of 2.44, expected move of 9.1%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 9.1% Sentiment56/100

Weighted news tone is neutral across 56 relevant articles.

ZBH5710697 Bond Profile — Key Metrics Insiders18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202693.93 USD2.8%89.72 USD103.1 USD0.65-7.2313.9MOff
24 Jul 202691.35 USD0.3%89.57 USD103.3 USD0.44-9.048.2MOff
17 Jul 202691.12 USD-0.2%89.53 USD103.6 USD0.52-10.1813.9MOff
10 Jul 202691.34 USD4.4%89.44 USD103.9 USD0.31-11.689.1MOff
3 Jul 202687.47 USD-6.0%89.42 USD104.2 USD0.13-14.6211.8MOff
26 Jun 202693.10 USD6.1%89.63 USD104.5 USD-0.08-7.5710.3MOff
19 Jun 202687.74 USD-0.7%89.75 USD104.8 USD-0.57-15.2210.7MOff
12 Jun 202688.34 USD1.4%89.87 USD105.1 USD-0.77-14.279.7MOff
5 Jun 202687.10 USD6.1%89.90 USD105.5 USD-0.93-15.3810.8MOff
29 May 202682.11 USD-3.7%89.92 USD105.8 USD-1.03-22.619.3MOff
22 May 202685.28 USD2.2%90.51 USD106.0 USD-0.75-18.9911.5MOff
15 May 202683.48 USD1.7%91.08 USD106.3 USD-0.45-20.4911.7MOff
8 May 202682.11 USD-0.7%91.66 USD106.6 USD-0.11-22.1510.2MOff
1 May 202682.68 USD-9.2%92.06 USD106.9 USD0.20-20.3824.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.